BRPI0916319A2 - processo para a preparação de esomeprazol magnésico em uma forma estável - Google Patents

processo para a preparação de esomeprazol magnésico em uma forma estável

Info

Publication number
BRPI0916319A2
BRPI0916319A2 BRPI0916319A BRPI0916319A BRPI0916319A2 BR PI0916319 A2 BRPI0916319 A2 BR PI0916319A2 BR PI0916319 A BRPI0916319 A BR PI0916319A BR PI0916319 A BRPI0916319 A BR PI0916319A BR PI0916319 A2 BRPI0916319 A2 BR PI0916319A2
Authority
BR
Brazil
Prior art keywords
preparation
stable form
esomeprazole magnesium
esomeprazole
magnesium
Prior art date
Application number
BRPI0916319A
Other languages
English (en)
Inventor
Toplak Casar Renata
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of BRPI0916319A2 publication Critical patent/BRPI0916319A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0916319A 2008-07-21 2009-07-20 processo para a preparação de esomeprazol magnésico em uma forma estável BRPI0916319A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08160826A EP2147918A1 (en) 2008-07-21 2008-07-21 Process for the preparation of S-omeprazole magnesium in a stable form
PCT/EP2009/059280 WO2010010056A1 (en) 2008-07-21 2009-07-20 Process for the preparation of esomeprazole magnesium in a stable form

Publications (1)

Publication Number Publication Date
BRPI0916319A2 true BRPI0916319A2 (pt) 2018-05-29

Family

ID=39970890

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0916319A BRPI0916319A2 (pt) 2008-07-21 2009-07-20 processo para a preparação de esomeprazol magnésico em uma forma estável

Country Status (9)

Country Link
US (1) US8362259B2 (pt)
EP (2) EP2147918A1 (pt)
CN (1) CN102159567B (pt)
AU (1) AU2009273276A1 (pt)
BR (1) BRPI0916319A2 (pt)
CA (1) CA2731254A1 (pt)
MX (1) MX2011000874A (pt)
RU (1) RU2011105878A (pt)
WO (1) WO2010010056A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011012957A1 (en) * 2009-07-29 2011-02-03 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of esomeprazole magnesium dihydrate
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
CN104844577A (zh) * 2011-07-31 2015-08-19 连云港润众制药有限公司 埃索美拉唑镁的晶型
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
WO2013088272A1 (en) * 2011-12-14 2013-06-20 Wockhardt Limited Pharmaceutical composition comprising esomeprazole magnesium dihydrate
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法
CN103539782A (zh) * 2013-10-16 2014-01-29 江南大学 一种埃索美拉唑镁盐二倍半水合物及其制备方法
FR3018812A1 (fr) 2014-03-21 2015-09-25 Minakem Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole
CN104370884A (zh) * 2014-10-29 2015-02-25 北京华睿鼎信科技有限公司 一种埃索美拉唑镁二水合物的制备方法
CN114315797B (zh) * 2022-03-08 2022-07-05 寿光富康制药有限公司 一种高晶型纯度艾司奥美拉唑镁二水合物晶体的制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE508669C2 (sv) 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
US6048981A (en) 1998-04-22 2000-04-11 Torcan Chemical Ltd. Magnesium omeprazole and process for its preparation
US6187726B1 (en) 1999-11-12 2001-02-13 Ck Witco Corporation Substituted linear thiourea additives for lubricants
CA2290893C (en) 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
US20030212274A1 (en) 2000-05-15 2003-11-13 Bakthavathsalan Vijayaraghavan Novel amorphous form of omeprazole salts
CA2386716C (en) 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
EP1546131A1 (en) 2002-08-30 2005-06-29 Dr. Reddy's Laboratories Ltd. Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
EA200500673A1 (ru) 2002-10-22 2005-12-29 Рэнбакси Лабораториз Лимитед Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе
US20040242642A1 (en) 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
US20060247277A1 (en) * 2003-02-28 2006-11-02 Yatendra Kumar Polymorphs of s-omeprazole
WO2004089935A1 (en) 2003-04-10 2004-10-21 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
US20050267159A1 (en) * 2004-05-28 2005-12-01 Aaipharma, Inc. Magnesium complexes of S-omeprazole
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
WO2006096709A2 (en) 2005-03-08 2006-09-14 Dr. Reddy's Laboratories Ltd. Process for preparing amorphous salts
WO2007031845A2 (en) 2005-09-14 2007-03-22 Glenmark Pharmaceuticals Limited Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
US7553857B2 (en) 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
JP2010519284A (ja) * 2007-02-21 2010-06-03 シプラ・リミテッド エソメプラゾールマグネシウム二水和物の調製方法

Also Published As

Publication number Publication date
WO2010010056A1 (en) 2010-01-28
EP2328887A1 (en) 2011-06-08
MX2011000874A (es) 2011-04-05
EP2147918A1 (en) 2010-01-27
CN102159567A (zh) 2011-08-17
CA2731254A1 (en) 2010-01-28
AU2009273276A1 (en) 2010-01-28
US20100016370A1 (en) 2010-01-21
CN102159567B (zh) 2014-08-06
US8362259B2 (en) 2013-01-29
RU2011105878A (ru) 2012-08-27

Similar Documents

Publication Publication Date Title
BRPI0916319A2 (pt) processo para a preparação de esomeprazol magnésico em uma forma estável
BRPI0916712A2 (pt) processo para preparar uma composição detergente
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
DOP2011000018A (es) Metodo y conjunto para productos tridimensionales
BRPI0908323A2 (pt) método para poduzir um artigo sobremoldado
BRPI0818872A2 (pt) Método para prevenir efeitos adversos por glp-1
BRPI0821944A2 (pt) Processo
BRPI0921718A2 (pt) composição, método para produzir uma composição, e, artigo moldado
EP2265932A4 (en) BIPLANES 3D MICROSCOPE
BRPI0919868A2 (pt) processo
BRPI0910662A2 (pt) processo para modificação de superfície de partículas
BRPI1007833A2 (pt) processo para produzir uma manta gofrada
PT2639224T (pt) Processos para produzir ácidos benzoicos cicloalquilcarboxamida-piridina
BRPI0921374A2 (pt) processo
BRPI1013561A8 (pt) processo para a preparação de alogliptina
BR112012031033A2 (pt) composição de si--g-poliolefina e processo para fazer uma composição de si-g-poliolefina
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
BRPI1006068A2 (pt) processo para produzir metacrilato de metila derivado de biomassa
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BRPI0925100A2 (pt) forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
BRPI0923574A2 (pt) processo para a preparação de uma forma em pó de peptídeo
BRPI0909393A2 (pt) processo para a preparação de polibutadieno
BR112012009097A2 (pt) processo para produzir colagens
BRPI0921420A2 (pt) processo para preparar compostos
BRPI0911634A2 (pt) processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2474 DE 05-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.